Quest Diagnostics
DGX
#1040
Rank
โ‚น1.588 T
Marketcap
โ‚น14,312
Share price
0.13%
Change (1 day)
32.43%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): โ‚น557.67

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น578.20. In 2022 the company made an earnings per share (EPS) of โ‚น689.39 a decrease over its 2021 EPS that were of โ‚น1,357.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น557.67-19.11%
2022โ‚น689.39-49.21%
2021โ‚น1,35749.72%
2020โ‚น906.6466.67%
2019โ‚น543.9818%
2018โ‚น461.02-4.26%
2017โ‚น481.5523.19%
2016โ‚น390.88-7.11%
2015โ‚น420.8228.46%
2014โ‚น327.59-31.61%
2013โ‚น478.9860.46%
2012โ‚น298.51-16.51%
2011โ‚น357.522.45%
2010โ‚น348.974.35%
2009โ‚น334.4330.77%
2008โ‚น255.7468.93%
2007โ‚น151.39-40.6%
2006โ‚น254.899.96%
2005โ‚น231.7910.39%
2004โ‚น209.9816.35%
2003โ‚น180.4726.73%
2002โ‚น142.4190.29%
2001โ‚น74.8453.51%
2000โ‚น48.75-22900%
1999-โ‚น0.21-101.11%
1998โ‚น19.24-216.88%
1997-โ‚น16.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น643.20 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น29.18-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น78.69-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น80.40-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น124.38-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands